Oxygen in the tumor microenvironment: effects on dendritic cell function.

Area of Science:

• Immunology
• Cancer Biology
• Cellular Physiology

Background:

• Solid tumors exhibit rapid growth, leading to tumor hypoxia and increased reactive oxygen species (ROS).
• Hypoxia and ROS significantly influence immune cells within the tumor micro-environment, altering their function.
• Dendritic cells (DCs) are critical for initiating anti-tumor adaptive immunity via T-cell activation.

Purpose of the Study:

• To review the multifaceted effects of hypoxia and ROS on dendritic cell (DC) function and physiology.
• To elucidate the mechanisms by which ROS may enter DCs and influence their activity.
• To understand how hypoxia and ROS interplay to modulate DC-mediated anti-tumor immune responses.

Main Methods:

• Literature review of studies investigating hypoxia, ROS, and dendritic cell function in the context of solid tumors.
• Analysis of proposed mechanisms for ROS entry into DCs (aquaporins, diffusion, extracellular vesicles).
• Examination of how hypoxia and ROS impact DC maturation, antigen presentation, and T-cell polarization.

Main Results:

• Hypoxia and ROS have complex, sometimes opposing, effects on immature DC maturation.
• ROS can enhance DC antigen (cross-)presentation via phagosomal alkalinization and protease modification.
• Hypoxia promotes a migratory, inflammatory DC phenotype and shifts T-cell responses towards a tumor-supportive T_h17 profile.

Conclusions:

• Hypoxia and ROS are interdependent effectors modulating DC function within the tumor micro-environment.
• Understanding the precise roles and interplay of hypoxia and ROS on DCs is vital for developing effective cancer immunotherapies.
• Targeting the hypoxia-ROS-DC axis may enhance adaptive anti-tumor immunity for tumor cell clearance.